Correction: Single-cell extracellular vesicle-program scoring maps immunometabolic rewiring and immune crosstalk of mesenchymal stromal cells in intervertebral disc degeneration, prioritizing AP2S1 and CSTB - Summary - MDSpire

Correction: Single-cell extracellular vesicle-program scoring maps immunometabolic rewiring and immune crosstalk of mesenchymal stromal cells in intervertebral disc degeneration, prioritizing AP2S1 and CSTB

  • By

  • Fengyu Ma

  • Kelv Shen

  • Ziqiang Wu

  • Hanshi Yang

  • Mingzhe Yu

  • Zhendong Huang

  • Fengxuan Han

  • Zhengfeng Lu

  • June 5, 2026

  • 0 min

Share

Objective:

To correct textual errors in the published article regarding the mapping of immunometabolic reprogramming and immune interaction of mesenchymal stromal cells in intervertebral disc degeneration.

Key Findings:
  • The correction in Section 3.1 clarifies the retention of cells for downstream analyses with the addition of a citation to Supplementary Figure 1.
  • The correction in Section 3.2 removes the incorrect citation to Figure 2C after reporting the 16 EV-score–linked genes.
Interpretation:

The authors state that these corrections do not change the data, analyses, results, interpretation, or conclusions of the article.

Limitations:
Conclusion:

The original version of the article has been updated to reflect these corrections.

Original Source(s)

Correction: Single-cell extracellular vesicle-program scoring maps immunometabolic rewiring and immune crosstalk of mesenchymal stromal cells in intervertebral disc degeneration, prioritizing AP2S1 and CSTB

  • by Fengyu Ma, Kelv Shen, Ziqiang Wu, Hanshi Yang, Mingzhe Yu, Zhendong Huang, Fengxuan Han, Zhengfeng Lu

  • June 5, 2026

Related Content

Evaluation and comparison of oral endotracheal tube depth prediction formulas in children with scoliosis: a retrospective study

CAA Use Tied to Higher Arthroplasty Risk

In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.

Comparison of clinical outcomes between cruciate-retaining and posterior-stabilized total knee arthroplasty in patients with mild to moderate patellofemoral joint osteoarthritis